Propanc Biopharma, Inc. Purchase Agreements

84 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Securities Purchase Agreement dated March 11, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement dated February 7, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement dated January 31, 2025
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2025
Securities Purchase Agreement dated December 4, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated December 15, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated September 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated August 2, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated June 20, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement dated June 10, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated May 22, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2024
Securities Purchase Agreement dated April 12, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2024
Securities Purchase Agreement dated March 1, 2024
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
CA
2024
Securities Purchase Agreement dated December 8, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement dated November 29, 2023
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of October 20, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of October 12, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement, dated as of August 23, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2023
Securities Purchase Agreement, dated as of August 16, 2023, by and between the Company and the August Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of July 19, 2023, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated as of June 29, 2022, by and between the Company and the June Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2023
Securities Purchase Agreement, dated November 3, 2022, by and between the Company and the Investor
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
DE
2023
Securities Purchase Agreement, dated February 14, 2023, by and between the Company and ONE44 Capital LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
2023
Securities Purchase Agreement, dated October 6, 2022, by and between the Company and Red Road Holdings Corporation
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated September 21, 2022, by and between the Company and GS Capital Partners, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated August 15, 2022, issued by the Company to ONE44 Capital LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated August 12, 2022, by and between the Company and GS Capital Partners, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated June 30, 2022, by and between the Company and 1800 Diagonal Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated May 12, 2022, by and between the Company and 1800 Diagonal Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated April 12, 2022, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated March 29, 2022, by and between the Company and ONE44 Capital LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2022
Securities Purchase Agreement, dated March 7, 2022, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated January 3, 2022, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2022
Securities Purchase Agreement, dated December 7, 2021, by and between the Company and ONE44 Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NV
2021
Securities Purchase Agreement, dated November 26, 2021, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Securities Purchase Agreement, dated October 21, 2021, by and between the Company and Sixth Street Lending LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
VA
2021
Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated January 5, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2021
Securities Purchase Agreement, dated December 10, 2020, by and between the Company and GW Holdings Group, LLC
Purchase Agreements
Propanc Biopharma, Inc.
Biotechnology
NY
2020